{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:28:21Z","timestamp":1784651301617,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NEKKEN","award":["28-Ippan-20"],"award-info":[{"award-number":["28-Ippan-20"]}]},{"DOI":"10.13039\/100016213","name":"University of Toyama","doi-asserted-by":"crossref","award":["Ippan Kenkyu I"],"award-info":[{"award-number":["Ippan Kenkyu I"]}],"id":[{"id":"10.13039\/100016213","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Herbal medicine has been a rich source of new drugs exemplified by quinine and artemisinin. In this study, a variety of Japanese traditional herbal medicine (\u2018\n                      <jats:italic>Kampo<\/jats:italic>\n                      \u2019) were examined for their potential anti-malarial activities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A comprehensive screening methods were designed to identify novel anti-malarial drugs from a library of Kampo herbal extracts (n\u2009=\u2009120) and related compounds (n\u2009=\u200996). The anti-malarial activity was initially evaluated in vitro against chloroquine\/mefloquine-sensitive (3D7) and-resistant (Dd2) strains of\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      . The cytotoxicity was also evaluated using primary adult mouse brain cells. After being selected through the first in vitro assay, positive extracts and compounds were examined for possible in vivo anti-malarial activity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 120 herbal extracts,\n                      <jats:italic>Coptis<\/jats:italic>\n                      rhizome showed the highest anti-malarial activity (IC\n                      <jats:sub>50<\/jats:sub>\n                      1.9\u00a0\u00b5g\/mL of 3D7 and 4.85\u00a0\u00b5g\/mL of Dd2) with a high selectivity index (SI)\u2009&gt;\u2009263 (3D7) and\u2009&gt;\u2009103 (Dd2). Three major chlorinated compounds (coptisine, berberine, and palmatine) related to\n                      <jats:italic>Coptis<\/jats:italic>\n                      rhizome also showed anti-malarial activities with IC\n                      <jats:sub>50<\/jats:sub>\n                      1.1, 2.6, and 6.0\u00a0\u00b5M (against 3D7) and 3.1, 6.3, and 11.8\u00a0\u00b5M (against Dd2), respectively. Among them, coptisine chloride exhibited the highest anti-malarial activity (IC\n                      <jats:sub>50<\/jats:sub>\n                      1.1\u00a0\u00b5M against 3D7 and 3.1\u00a0\u00b5M against Dd2) with SI of 37.8 and 13.2, respectively. Finally, the herbal extract of\n                      <jats:italic>Coptis<\/jats:italic>\n                      rhizome and its major active compound coptisine chloride exhibited significant anti-malarial activity in mice infected with\n                      <jats:italic>Plasmodium yoelii<\/jats:italic>\n                      17X strain with respect to its activity on parasite suppression consistently from day 3 to day 7 post-challenge. The effect ranged from 50.38 to 72.13% (P\u2009&lt;\u20090.05) for\n                      <jats:italic>Coptis<\/jats:italic>\n                      rhizom\n                      <jats:italic>e<\/jats:italic>\n                      and from 81 to 89% (P\u2009&lt;\u20090.01) for coptisine chloride.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Coptis<\/jats:italic>\n                      rhizome and its major active compound coptisine chloride showed promising anti-malarial activity against chloroquine-sensitive (3D7) and -resistant (Dd2) strains in vitro as well as in vivo mouse malaria model. Thus, Kampo herbal medicine is a potential natural resource for novel anti-malarial agents.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12936-020-03273-x","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T08:05:46Z","timestamp":1591603546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-malarial activity of traditional Kampo medicine Coptis rhizome extract and its major active compounds"],"prefix":"10.1186","volume":"19","author":[{"given":"Awet Alem","family":"Teklemichael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusaku","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Toume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Mosaddeque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Gomaa","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuko","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntra","family":"Karbwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tien","family":"Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9467-1777","authenticated-orcid":false,"given":"Kenji","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"3273_CR1","volume-title":"World malaria report 2019","author":"WHO","year":"2019","unstructured":"WHO. World malaria report 2019. Geneva: World Health Organization; 2019."},{"key":"3273_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/14760584.2019.1561289","volume":"18","author":"KL Wilson","year":"2019","unstructured":"Wilson KL, Flanagan KL, Prakash MD, Plebanski M. Malaria vaccines in the eradication era: current status and future perspectives. Expert Rev Vaccines. 2019;18:133\u201351.","journal-title":"Expert Rev Vaccines."},{"key":"3273_CR3","first-page":"502","volume":"20","author":"M Zucca","year":"2013","unstructured":"Zucca M, Scutera S, Savoia D. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases. Curr Med Chem. 2013;20:502\u201326.","journal-title":"Curr Med Chem"},{"key":"3273_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd1416","volume":"3","author":"DA Fidock","year":"2004","unstructured":"Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov. 2004;3:509\u201320.","journal-title":"Nat Rev Drug Discov."},{"key":"3273_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/trstmh\/tru101","volume":"108","author":"AP Mnzava","year":"2014","unstructured":"Mnzava AP, Macdonald MB, Knox TB, Temu EA, Shiff CJ. Malaria vector control at a crossroads: public health entomology and the drive to elimination. Trans R Soc Trop Med Hyg. 2014;108:550\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3273_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0020-7519(96)00152-X","volume":"27","author":"M Foley","year":"1997","unstructured":"Foley M, Tilley L. Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol. 1997;27:231\u201340.","journal-title":"Int J Parasitol"},{"key":"3273_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"J Achan","year":"2011","unstructured":"Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.","journal-title":"Malar J."},{"key":"3273_CR8","first-page":"323","volume":"63","author":"BE Monjol","year":"2017","unstructured":"Monjol BE, Useh MF. Detection of Plasmodium falciparum chloroquine resistance transporter (PfCRT) mutant gene amongst malaria-infected pregnant women in Calabar, Nigeria. Ann Parasitol. 2017;63:323\u201330.","journal-title":"Ann Parasitol."},{"key":"3273_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0169-4758(87)90147-5","volume":"3","author":"D Payne","year":"1987","unstructured":"Payne D. Spread of chloroquine resistance in Plasmodium falciparum. Parasitol Today. 1987;3:241\u20136.","journal-title":"Parasitol Today."},{"key":"3273_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/2229-5070.175081","volume":"6","author":"HA Antony","year":"2016","unstructured":"Antony HA, Parija SC. Antimalarial drug resistance: an overview. Trop Parasitol. 2016;6:30\u201341.","journal-title":"Trop Parasitol."},{"key":"3273_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40249-016-0217-7","volume":"6","author":"A Sowunmi","year":"2017","unstructured":"Sowunmi A, Akano K, Ntadom G, Ayede AI, Ibironke FO, Aderoyeje T, et al. Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria-associated anaemia in Nigerian children during seven years of adoption as first-line treatments. Infect Dis Poverity. 2017;6:36.","journal-title":"Infect Dis Poverity."},{"key":"3273_CR12","unstructured":"WHO. Antimalarial drug resistance in the Greater Mekong Subregion: how concerned should we be? Geneva: World Health Organization; 2017. http:\/\/www.who.int\/malaria\/media\/drug-resistance-greater-mekong-qa\/en\/. Accessed 6 Mar 2018."},{"key":"3273_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","volume":"18","author":"R Amato","year":"2018","unstructured":"Amato R, Pearson RD, Almagro-Garcia J, Amaratunga C, Lim P, Suon S, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18:337\u201345.","journal-title":"Lancet Infect Dis."},{"key":"3273_CR14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis."},{"key":"3273_CR15","doi-asserted-by":"publisher","first-page":"17109","DOI":"10.1038\/nplants.2017.109","volume":"3","author":"F-S Li","year":"2017","unstructured":"Li F-S, Weng J-K. Demystifying traditional herbal medicine with modern approach. Nat Plants. 2017;3:17109.","journal-title":"Nat Plants."},{"key":"3273_CR16","first-page":"79","volume":"37","author":"S Norn","year":"2009","unstructured":"Norn S, Permin H, Kruse PR, Kruse E. From willow bark to acetylsalicylic acid. Dan Medicinhist Arbog. 2009;37:79\u201398 (in Danish).","journal-title":"Dan Medicinhist Arbog."},{"key":"3273_CR17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s40256-018-0292-1","volume":"18","author":"TF Whayne","year":"2018","unstructured":"Whayne TF. Clinical use of digitalis: a state of the art review. Am J Cardiovasc Drug. 2018;18:427\u201340.","journal-title":"Am J Cardiovasc Drug."},{"key":"3273_CR18","first-page":"171","volume":"33","author":"S Norn","year":"2005","unstructured":"Norn S, Kruse PR, Kruse E. History of opium poppy and morphine. Dan Medicinhist Arbog. 2005;33:171\u201384 (in Danish).","journal-title":"Dan Medicinhist Arbog."},{"key":"3273_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/molecules21050559","volume":"21","author":"H Yuan","year":"2016","unstructured":"Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:559.","journal-title":"Molecules"},{"key":"3273_CR20","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12936-019-3026-1","volume":"18","author":"N Tajuddeen","year":"2019","unstructured":"Tajuddeen N, Van Heerden FR. Antiplasmodial natural products: an update. Malar J. 2019;18:404.","journal-title":"Malar J."},{"key":"3273_CR21","first-page":"9","volume":"44","author":"H Permin","year":"2016","unstructured":"Permin H, Norn S, Kruse E, Kruse PR. On the history of Cinchona bark in the treatment of malaria. Dan Medicinhistorisk Arbog. 2016;44:9\u201330.","journal-title":"Dan Medicinhistorisk Arbog."},{"key":"3273_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4269\/ajtmh.16-0138","volume":"95","author":"GD Shanks","year":"2016","unstructured":"Shanks GD. Problematic malaria prophylaxis with quinine. Am J Trop Med Hyg. 2016;95:269\u201372.","journal-title":"Am J Trop Med Hyg"},{"key":"3273_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/0141076816688411","volume":"110","author":"G Gachelin","year":"2017","unstructured":"Gachelin G, Garner P, Ferroni E, Tr\u00f6hler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J Roy Soc Med. 2017;110:73\u201382.","journal-title":"J Roy Soc Med."},{"key":"3273_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jep.2008.09.017","volume":"120","author":"S de Ridder","year":"2008","unstructured":"de Ridder S, van der Kooy F, Verpoorte R. Artemisia annua as a self-reliant treatment for malaria in developing countries. J Ethnopharmacol. 2008;120:302\u201314.","journal-title":"J Ethnopharmacol"},{"key":"3273_CR25","doi-asserted-by":"crossref","unstructured":"WHO. Traditional medicine. Geneva: World Health Organization; 2019. https:\/\/www.afro.who.int\/health-topics\/traditional-medicine. Accessed 1 Apr 2019.","DOI":"10.1007\/978-1-4614-6439-6_76-2"},{"key":"3273_CR26","first-page":"525340","volume":"2014","author":"S-Y Pan","year":"2014","unstructured":"Pan S-Y, Litscher G, Gao S-H, Zhou S-F, Yu Z-L, Chen H-Q, et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complementary Altern Med. 2014;2014:525340.","journal-title":"Evid Based Complementary Altern Med."},{"key":"3273_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fphar.2016.00219","volume":"7","author":"KM Hoffmann","year":"2016","unstructured":"Hoffmann KM, Herbrechter R, Ziemba PM, Lepke P, Beltr\u00e1n L, Hatt H, et al. Kampo medicine: evaluation of the pharmacological activity of 121 herbal drugs on GABAA and 5-HT3A receptors. Front Pharmacol. 2016;7:219.","journal-title":"Front Pharmacol."},{"key":"3273_CR28","doi-asserted-by":"publisher","first-page":"42325","DOI":"10.1038\/srep42325","volume":"7","author":"X Chen","year":"2017","unstructured":"Chen X, Xiang L, Shi L, Li G, Yao H, Han J, et al. Identification of crude drugs in the Japanese pharmacopoeia using a DNA barcoding system. Sci Rep. 2017;7:42325.","journal-title":"Sci Rep."},{"key":"3273_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1472-6882-12-207","volume":"12","author":"M Arai","year":"2012","unstructured":"Arai M, Katai S, Muramatsu S-I, Namiki T, Hanawa T, Izumi S-I. Current status of Kampo medicine curricula in all Japanese medical schools. BMC Complem Altern Med. 2012;12:207.","journal-title":"BMC Complem Altern Med."},{"key":"3273_CR30","doi-asserted-by":"publisher","first-page":"535146","DOI":"10.1155\/2014\/535146","volume":"2014","author":"S Yakubo","year":"2014","unstructured":"Yakubo S, Ito M, Ueda Y, Okamoto H, Kimura Y, Amano Y, et al. Pattern classification in Kampo medicine. Evid Based Complemen Altern Med. 2014;2014:535146.","journal-title":"Evid Based Complemen Altern Med."},{"key":"3273_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12911-016-0361-9","volume":"16","author":"T Yoshino","year":"2016","unstructured":"Yoshino T, Katayama K, Horiba Y, Munakata K, Yamaguchi R, Imoto S, et al. Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study. BMC Med Inform Decis Mak. 2016;16:118.","journal-title":"BMC Med Inform Decis Mak"},{"key":"3273_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11655-011-0653-y","volume":"17","author":"Y Motoo","year":"2011","unstructured":"Motoo Y, Seki T, Tsutani K. Traditional Japanese medicine, Kampo: its history and current status. Chin J Integr Med. 2011;17:85\u20137.","journal-title":"Chin J Integr Med."},{"key":"3273_CR33","doi-asserted-by":"crossref","first-page":"513842","DOI":"10.1093\/ecam\/neq067","volume":"2011","author":"K Watanabe","year":"2011","unstructured":"Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, et al. Traditional Japanese Kampo medicine: clinical research between modernity and traditional medicine\u2014the state of research and methodological suggestions for the future. Evid Based Complementary Altern Med. 2011;2011:513842.","journal-title":"Evid Based Complementary Altern Med."},{"key":"3273_CR34","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/273621a0","volume":"273","author":"W Trager","year":"1978","unstructured":"Trager W, Jensen JB. Cultivation of malarial parasites. Nature. 1978;273:621\u20132.","journal-title":"Nature"},{"key":"3273_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00117826","volume":"3","author":"E Borenfreund","year":"1987","unstructured":"Borenfreund E, Babich H. In vitro cytotoxicity of heavy metals, acrylamide, and organotin salts to neural cells and fibroblasts. Cell Biol Toxicol. 1987;3:63\u201373.","journal-title":"Cell Biol Toxicol"},{"key":"3273_CR36","unstructured":"TradMPD. Traditional Medical & Pharmaceutical Database. http:\/\/dentomed.toyama-wakan.net\/en\/information_on_experimental_crude_drug_extracts\/. Accessed 1 May 2020."},{"key":"3273_CR37","doi-asserted-by":"publisher","first-page":"e02424\u201317","DOI":"10.1128\/AAC.02424-17","volume":"62","author":"F Mosaddeque","year":"2018","unstructured":"Mosaddeque F, Mizukami S, Kamel MG, Teklemichael AA, Dat TV, Mizuta S, et al. Prediction model for antimalarial activities of hemozoin inhibitors by using physicochemical properties. Antimicrob Agents Chemother. 2018;62:e02424\u201317.","journal-title":"Antimicrob Agents Chemother"},{"key":"3273_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.3918","author":"Y Yan","year":"2017","unstructured":"Yan Y, Zhang H, Zhang Z, Song J, Chen Y, Wang X, et al. Pharmacokinetics and tissue distribution of coptisine in rats after oral administration by liquid chromatography-mass spectrometry. Biomed Chromatogr. 2017. https:\/\/doi.org\/10.1002\/bmc.3918.","journal-title":"Biomed Chromatogr."},{"key":"3273_CR39","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1248\/bpb.b15-00293","volume":"38","author":"J Su","year":"2015","unstructured":"Su J, Miao Q, Miao P, Zhao Y, Zhang Y, Chen N, et al. Pharmacokinetics and brain distribution and metabolite identification of coptisine, a protoberberine alkaloid with therapeutic potential for CNS disorders, in rats. Biol Pharm Bull. 2015;38:1518\u201328.","journal-title":"Biol Pharm Bull"},{"key":"3273_CR40","first-page":"115","volume":"42","author":"AR Parhizgar","year":"2017","unstructured":"Parhizgar AR, Tahghighi A. Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review. Iran J Med Sci. 2017;42:115\u201328.","journal-title":"Iran J Med Sci."},{"key":"3273_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2017.09.001","volume":"435","author":"M Ca\u00f1\u00f3n","year":"2017","unstructured":"Ca\u00f1\u00f3n M, Diaz H, Olarte A. Mathematical model for the spread of drug resistance in Plasmodium falciparum parasite considering transmission conditions. J Theor Biol. 2017;435:1\u201311.","journal-title":"J Theor Biol"},{"key":"3273_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12936-018-2185-9","volume":"17","author":"C Nsanzabana","year":"2018","unstructured":"Nsanzabana C, Djalle D, Gu\u00e9rin PJ, M\u00e9nard D, Gonz\u00e1lez IJ. Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape. Malar J. 2018;17:75.","journal-title":"Malar J."},{"key":"3273_CR43","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11418-017-1107-4","volume":"71","author":"A Fujii","year":"2017","unstructured":"Fujii A, Okuyama T, Wakame K, Okumura T, Ikeya Y, Nishizawa M. Identification of anti-inflammatory constituents in Phellodendri cortex and Coptidis Rhizoma by monitoring the suppression of nitric oxide production. J Nat Med. 2017;71:745\u201356.","journal-title":"J Nat Med"},{"key":"3273_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s11418-018-1209-7","volume":"72","author":"N Oshima","year":"2018","unstructured":"Oshima N, Shimizu T, Narukawa Y, Hada N, Kiuchi F. Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production. J Nat Med. 2018;72:706\u201314.","journal-title":"J Nat Med"},{"key":"3273_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jep.2016.03.028","volume":"185","author":"Y Chen","year":"2016","unstructured":"Chen Y, Xian Y, Lai Z, Loo S, Chan WY, Lin Z-X. Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: implication for atopic dermatitis treatment. J Ethnopharmacol. 2016;185:41\u201352.","journal-title":"J Ethnopharmacol"},{"key":"3273_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12936-018-2392-4","volume":"17","author":"M Nonaka","year":"2018","unstructured":"Nonaka M, Murata Y, Takano R, Han Y, Kabir MHB, Kato K. Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts. Malar J. 2018;17:244.","journal-title":"Malar J."},{"key":"3273_CR47","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1128\/AAC.01881-12","volume":"57","author":"DW Wilson","year":"2013","unstructured":"Wilson DW, Langer C, Goodman CD, McFadden GI, Beeson JG. Defining the timing of action of antimalarial drugs against Plasmodium falciparum. Antimicrob Agents Chemother. 2013;57:1455\u201367.","journal-title":"Antimicrob Agents Chemother"},{"key":"3273_CR48","doi-asserted-by":"publisher","first-page":"602436","DOI":"10.1155\/2014\/602436","volume":"2014","author":"H Mahmoudvand","year":"2014","unstructured":"Mahmoudvand H, Ayatollahi Mousavi SA, Sepahvand A, Sharififar F, Ezatpour B, et al. Antifungal, antileishmanial, and cytotoxicity activities of various extracts of Berberis vulgaris (Berberidaceae) and its active principle Berberine. ISRN Pharmacol. 2014;2014:602436.","journal-title":"ISRN Pharmacol."},{"key":"3273_CR49","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jprot.2012.03.010","volume":"75","author":"H-C Chou","year":"2012","unstructured":"Chou H-C, Lu Y-C, Cheng C-S, Chen Y-W, Lyu P-C, Lin C-W, et al. Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics. 2012;75:3158\u201376.","journal-title":"J Proteomics."},{"key":"3273_CR50","first-page":"3018498","volume":"2018","author":"L El Khalki","year":"2018","unstructured":"El Khalki L, Tilaoui M, Jaafari A, Ait Mouse H, Zyad A. Studies on the dual cytotoxicity and antioxidant properties of Berberis vulgaris extracts and its main constituent berberine. Adv Pharmacol Sci. 2018;2018:3018498.","journal-title":"Adv Pharmacol Sci"},{"key":"3273_CR51","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.phymed.2017.12.027","volume":"48","author":"B Han","year":"2018","unstructured":"Han B, Jiang P, Li Z, Yu Y, Huang T, Ye X, et al. Coptisine-induced apoptosis in human colon cancer cells (HCT-116) is mediated by PI3K\/Akt and mitochondrial-associated apoptotic pathway. Phytomedicine. 2018;48:152\u201360.","journal-title":"Phytomedicine"},{"key":"3273_CR52","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3390\/molecules23113039","volume":"23","author":"S Fu","year":"2018","unstructured":"Fu S, Ni S, Wang D, Hong T. Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis. Molecules. 2018;23:3039.","journal-title":"Molecules"},{"key":"3273_CR53","doi-asserted-by":"publisher","first-page":"172523","DOI":"10.1016\/j.ejphar.2019.172523","volume":"859","author":"L-L Shi","year":"2019","unstructured":"Shi L-L, Jia W-H, Zhang L, Xu C-Y, Chen X, Yin L, et al. Glucose consumption assay discovers coptisine with beneficial effect on diabetic mice. Eur J Pharmacol. 2019;859:172523.","journal-title":"Eur J Pharmacol"},{"key":"3273_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.14336\/AD.2016.0620","volume":"8","author":"Z Xu","year":"2017","unstructured":"Xu Z, Feng W, Shen Q, Yu N, Yu K, Wang S, Chen Z, et al. Rhizoma coptidis and berberine as a natural drug to combat aging and aging-related diseases via anti-oxidation and AMPK activation. Aging Dis. 2017;8:760\u201377.","journal-title":"Aging Dis."},{"key":"3273_CR55","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18:41\u201358.","journal-title":"Nat Rev Drug Discov."},{"key":"3273_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello SM, Bittker JA, Liu Z, Gould J, McCarren P, Hirschman JE, et al. The Drug Repurposing Hub: a next-generation drug library and information resource. Nat Med. 2017;23:405\u20138.","journal-title":"Nat Med"},{"key":"3273_CR57","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S1473-3099(18)30176-2","volume":"18","author":"NR Rabinovich","year":"2018","unstructured":"Rabinovich NR. Ivermectin: repurposing an old drug to complement malaria vector control. Lancet Infect Dis. 2018;18:584\u20135.","journal-title":"Lancet Infect Dis."}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-020-03273-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T19:41:10Z","timestamp":1623094870000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3273"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03273-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.19890\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19890\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.19890\/v3","asserted-by":"object"}]},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"27 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}